Dr. John Cush RheumNow
1 year ago
How do we manage difficult discussions about pregnancy in RA?
Most rheums know that it is important to get pregnancy planning right for women of childbearing age living with rheumatic diseases. That is easier said than done, though...
https://t.co/cXtqqVv6fp https://t.co/k5afTUKYf8
ARD & RMD Open ARD_BMJ
1 year ago
L20 at #ACR23
Phase 3 RCT of #Telitacicept vs. placebo in #RA
☝🏻B-cell neutralization by targeting BlyS and APRIL
✅ better ACR20 and 50 response at W24
✅ favorable structural response
✅ good safety profile
❓ few seronegative patients
A new small molecule to treat #RA?
PAJ https://t.co/fyrqAya41e
Elena MyasoedovaMD ☀️
1 year ago
#ACR23 #EdLovering presenting on association b/w #RA, #CVD & #Dementia:
👉🏻CVD is not a signif mediator b/w RA &Dementia
👉🏻 signif synergy b/w RA & CVD on dementia (HR 2.45 vs those w/o RA&CVD)
👉🏻 ⬆️ risk of dementia in RA mostly in people with RA+CVD
#Mayoclinicrheumatology https://t.co/5kqs3HAACn
Nigil Haroon MD, PhD, DM, FRCPC, FRCP, MBA NigilHaroon
1 year ago
The dynamic Dr. Vinod Chandran, talking about metabolomics in #psoriaticDisease
#ACR23
The metabolomics facility was established recently at the @UHN @UofT @SchroederInst and we are already seeing the results. @KrembilF @CRASCRRheum @UofTRheum https://t.co/Azxq3k8w5g
Jeffrey Sparks MD MMSc jeffsparks
1 year ago
Impressive and important study supporting safety of TNF inhibitors among patients with RA-ILD. Elegant methods of target trial emulation. Congrats to the authors on plenary presentation!
#ACR23 https://t.co/P7keAoOX7M
The Lancet Rheumatology TheLancetRheum
1 year ago
🔥 HOT OFF THE PRESS for #ACR23
Effectiveness of a fourth dose of #COVID19 mRNA #vaccine in patients with systemic autoimmune rheumatic diseases using DMARDs: an emulated target trial https://t.co/bvc75BP4aG @zach_wallace_md @jeffsparks https://t.co/CAlgjvUr9X
Adam J Brown
1 year ago
Something to listen to on the way home from #ACR23
The last episode in a 4 part series on the environment and autoimmunity
What does silica exposure have to do with autoimmunity?
https://t.co/2Vqi22xqCw
Tue Kragstrup KragstrupTW
1 year ago
Nipocalimab (say it a couple of times) is a FcRn (neonatal Fc receptor) inhibitor. In short promotes degradation of IgG incl autoantibodies (and investigated in myasthenia).
Prof Taylor presents that it might work in CCP high titer RA at #ACR23.
#ACRambassador @ACRheum https://t.co/DqlsOv7AVI
Dr Gurdeep S Dulay
1 year ago
Reminder of data for dose reduction #bDMARD by Prof Emery #ACR23
Feasible after early remission induction https://t.co/WwiNp8WKDC
Rohit Aggarwal
1 year ago
Thanks #ACR23 for a wonderful meeting ! Presented a really positive phase 2 clinical trial results of Dazukibart, an IFN beta monoclonal antibody in #Myositis (DM) #pfizer
.Strong efficacy with rapid onset. Safe & tolerable monthly IV injection. Looking forward to start Phase 3. https://t.co/580ICHM8Hs
Jeffrey Sparks MD MMSc jeffsparks
1 year ago
Just presented at #ACR23 by Dr Jennifer Hanberg @Jen_LS_Hanberg and published at @TheLancetRheum.!
Effectiveness of 4th mRNA COVID dose on breakthrough infection @zach_wallace_md
https://t.co/PXc2THn217
Tanmayee Bichile, MD
1 year ago
Chikungunya - takeaway points
🪔Acute arthritis in large joints , polyarthritis and tenosynovitis in hands
🪔 Associated with travel history to Africa/Asia/Asia Pacific
🪔<5% develop chronic arthritis
#ACR23
#ACRambassador https://t.co/yzZDpy70i3
Dr. John Cush RheumNow
1 year ago
Maintain Vigilance for CV Risk Postpartum in Autoimmune Diseases
Pregnant women with ARDs and APS face significantly increased risks of CVEs. This increased risk is often attributed to ARDs, its medications or comorbidities associated with it.
https://t.co/KwMEwlr7Af https://t.co/vDt4B8jtt6
David Liew drdavidliew
1 year ago
Look if I’m going to be rheumatology writing on a Wednesday night in LA post-#ACR23 then it might as well be with a bulgogi cheesesteak (loaded with jalapeño) and a negroni @MamaShelterLA https://t.co/OsqKb2EkET
TheDaoIndex KDAO2011
1 year ago
Does anyone feel like Lassie? #Wellness #RheumGR Talk by Dr. Wiles @UTSWIMchief @UTSWRheum https://t.co/7HG4vD95JQ